24 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

WIREGUIDE OR GUIDEWIRE

FDA 510(k)
FDA Class 2 ·Cardiovascular

DD cubeY® HL

FDA UDI
Dental Direkt GmbH·EDDIG8430121·The DD cubeY® HL zirconium dioxide milling blan...

Buxton Biomedical

FDA UDI
Buxton Biomedical Inc·B7688430120·Sm-Hndl Punch, 180x1mm,40°up

OMNIPULSE MINI, MODEL 2120

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

MIM – Symphony HDR Fusion

FDA 510(k)
FDA Class 2 ·Radiology

VerSys®

FDA UDI
Zimmer, Inc.·00889024136496·

VerSys®

FDA UDI
Zimmer, Inc.·00889024136526·

VerSys®

FDA UDI
Zimmer, Inc.·00889024136502·

VerSys®

FDA UDI
Zimmer, Inc.·00889024136465·

VerSys®

FDA UDI
Zimmer, Inc.·00889024136519·

VerSys®

FDA UDI
Zimmer, Inc.·00889024136472·

VerSys®

FDA UDI
Zimmer, Inc.·00889024136489·

NA

FDA UDI
Zimmer, Inc.·00889024195066·

NA

FDA UDI
Zimmer, Inc.·00889024195073·

HEARTSTART FRX

FDA Adverse Event
Malfunction ·PHILIPS MEDICAL SYSTEMS·Product code MKJ·March 13, 2014

RX ACCULINK CAROTID STENT SYSTEM

FDA Adverse Event
Malfunction ·AV-TEMECULA-CT·Product code NIM·November 21, 2012

RENAL - DISPOSABLE

FDA Adverse Event
Injury ·Product code KDJ·September 23, 2010

VERSYS 6 INCH BEADED FC 12X160MM LM BODY EXT NECK VERSYS BEADED FULLCOAT REVISION HIP PROSTHESIS

FDA Enforcement
Class II ·Terminated·Zimmer Biomet, Inc.·March 21, 2018

VERSYS 6 INCH BEADED FC STEM 12X160MM LM 13X160MM LM 15X160MM LM 17X160MM LM Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented

FDA Enforcement
Class II ·Terminated·Zimmer Biomet, Inc.·March 21, 2018

VERSYS 6 INCH BEADED FC 1 prosthesis, hip, semi-constrained, metal/polymer, porous uncemented "" Total hip replacement for the following: severe hip pain and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head, nonunion of previous fractures of the femur; congenital hip dysplasia, protrusio acetabuli, slipped capital femoral epiphysis; disability due to previous fusion; previously failed endoprostheses, and/or total hip components in the affected extremity and acute femoral neck fractures. " Hemi-hip replacement for the following: fracture dislocation of the hip; elderly, debilitated patients when a total hip replacement is contraindicated; irreducible fractures in which adequate fixation cannot be obtained; certain high subcapital fractures and comminuted femoral neck fractures in the aged; nonunion of femoral neck fractures; secondary avascular necrosis of the femoral head; pathological fractures of the femoral neck; and osteoarthritis in which the femoral head is primarily affected."

FDA Enforcement
Class II ·Terminated·Zimmer Biomet, Inc.·March 2, 2016